Back to search

France· FR:68019053

THERASOLV 25 000 UI, poudre pour solution injectable/pour perfusion

A medicinal product containing urokinase (mammifere/humain/urine), registered in France by THERADIAL.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedTHERASOLV 25 000 UI, poudre pour solu…ATC—REGISTER NO.FR:68019053PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
UROKINASE (MAMMIFERE/HUMAIN/URINE)
Manufacturer
THERADIAL
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955067542
    1 flacon(s) en verre de 8 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Urokinase (mammifere/humain/urine) in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All urokinase (mammifere/humain/urine) products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Austria · Urokinase Medac
  • Belgium · Actosolv, Urokinase Syner-Medica
  • Germany · Rheotromb, Syner-Kinase
  • Spain · Urokinase Teofarma, Uroquinasa Syner Medica
  • United Kingdom (Northern Ireland) · Syner-Kinase
  • Italy · Urochinasi Eg, Urokinasi Pfizer
  • Luxembourg · Actosolv
  • Netherlands · Urokinase Devrimed, Urokinase Pharma-Zentrale
  • Poland · Urokinase Medac

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7c42a0b2-392c-4d65-acf2-7b58ebde69bf
GET /v1/drugs/7c42a0b2-392c-4d65-acf2-7b58ebde69bf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68019053",
  "date_amm": "2019-07-02",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "UROKINASE (MAMMIFERE/HUMAIN/URINE)",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour solution injectable ou pour perfusion",
  "voies_administration": "intraartérielle;intraveineuse;voie extracorporelle autre",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about urokinase (mammifere/humain/urine).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.